Search all CIRM Grants
Information about disease focus, human stem cell use or new cell line generation will typically not be available on the website until a few months after the award is announced. Disease categories are provided for awards that might impact a given disease or related area, whether those awards are for translational research on new therapy candidates or for basic research to address a biological question that is relevant to that disease.
|Institution||Researcher name||Grant Type||Grant Title||ICOC Approved Funds|
|ViaCyte, Inc.||Emmanuel Baetge||Disease Team Planning||Development of a Cell Replacement Therapy Product for Insulin Dependent Diabetes||$48,950|
|ViaCyte, Inc.||Allan Robins||Disease Team Research I||Cell Therapy for Diabetes||$22,999,937|
|ViaCyte, Inc.||Evert Kroon||Tools and Technologies I||Development of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors.||$827,072|
|ViaCyte, Inc.||Olivia Kelly||Early Translational I||Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product||$5,405,397|
|ViaCyte, Inc.||Howard Foyt||Strategic Partnership I||Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes||$10,075,070|